- Home
- FLOC vs LBRX Comparison
FLOC vs LBRX Comparison
Compare FLOC & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLOC | LBRX |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 509.0M | 563.2M |
| IPO Year | 2025 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FLOC | LBRX |
|---|---|---|
| Price | $20.43 | $19.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $30.17 | ★ $49.00 |
| AVG Volume (30 Days) | 222.4K | ★ 471.0K |
| Earning Date | 11-05-2025 | 02-15-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $748,499,000.00 | N/A |
| Revenue This Year | $43.28 | N/A |
| Revenue Next Year | $7.88 | N/A |
| P/E Ratio | $14.85 | ★ N/A |
| Revenue Growth | ★ 76.22 | N/A |
| 52 Week Low | $14.03 | $13.36 |
| 52 Week High | $30.50 | $23.15 |
Technical Indicators
Market Signals| Indicator | FLOC | LBRX |
|---|---|---|
| Relative Strength Index (RSI) | 72.65 | N/A |
| Support Level | $19.02 | N/A |
| Resistance Level | $20.33 | N/A |
| Average True Range (ATR) | 0.66 | 0.00 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 95.06 | 0.00 |
Price Performance
Historical ComparisonAbout FLOC Flowco Holdings Inc.
Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.
About LBRX LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.